2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Postoperative Complications
1
Polycystic Ovary Syndrome
1
Pituitary Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Insulin Resistance
1
Hypopituitarism
1
Dwarfism, Pituitary
1
Dwarfism
1
Atherosclerosis
1
Interventions
Metformin
7
Testosterone
2
Pioglitazone
2
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
Blood Pressure
2
semaglutide
1
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Ultrasonography
1
Triptorelin Pamoate
1
Topiramate
1
Tirzepatide
1
Sugars
1
Spironolactone
1
Qsymia
1
Pyruvic Acid
1
Pulse Wave Analysis
1
Preoperative Exercise
1
Phlebotomy
1
Phentermine
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Growth Hormone
×
Clear all
NCT00462475
2007-10-16
5yrGH
Federico II University
Completed
20 enrolled